Albany Molecular Research Inc logo

AMRI - Albany Molecular Research Inc News Story

$21.74 0.0  0.0%

Last Trade - 31/08/17

Sector
Healthcare
Size
Micro Cap
Market Cap £n/a
Enterprise Value £n/a
Revenue £551.5m
Position in Universe th / 6364

BRIEF-AMRI announces early termination of HSR waiting period for Carlyle Group, GTCR's proposed acquisition

Thu 29th June, 2017 1:00pm
June 29 (Reuters) - Albany Molecular Research Inc  AMRI.O : 
    * AMRI announces early termination of Hart-Scott-Rodino 
waiting period for the Carlyle Group and GTCR's proposed 
acquisition of AMRI 
    * Albany Molecular Research Inc - it is anticipated that 
special meeting of AMRI's stockholders to vote on transaction 
will be held in Q3 of 2017 
 
Source text for Eikon:  ID:nPn3VRqYva  
Further company coverage:  AMRI.O  
 
 ((Bangalore.newsroom@thomsonreuters.com;))
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.